The prothrombin 20210 G to A variation and thrombosis

Current Opinion in Hematology

Volumn 5, Issue 5, 1998, Pages 339-342

  Bertina, Rogier M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; BLOOD CLOTTING FACTOR 5; GUANINE; PROTHROMBIN;

ALLELE; CARDIOVASCULAR RISK; GENETIC RISK; HETEROZYGOSITY; HUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SMOKING; THROMBOSIS; VEIN THROMBOSIS;

EID: 0031694967     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199809000-00006     Document Type: Review

References (34)

1. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov •• V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, et al.: Inherited thrombophilia: part I. Thromb Haemost 1996, 76:651-662. This excellent review of all aspects of thrombophilia is based on the World Health Organization report of a joint World Health Organization-International Society on Thrombosis and Haemostasis meeting (Geneva, 1995).
2. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov •• V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, et al.: Inherited thrombophilia: part 2, Thromb Haemost 1996, 76:824-834. This excellent review of all aspects of thrombophilia is based on the World Health Organization report of a joint World Health Organization-International Society on Thrombosis and Haemostasis meeting (Geneva, 1995).
3. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, De Ronde H, Van der Velden PA, Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994, 369:64-67.
4. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM: A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996, 88:3698-3703.
5. Degen SJF, Davie EW: Nucleotide sequence of the gene for human prothrombin. Biochemistry 1987, 26:6165-6177.
6. Poort SR, Bertina RM, Vos HL: Rapid detection of the prothrombin 20210A variation by allele specific PCR. Thromb Haemost 1997, 78:1157-1158.
7. Ferraresi P, Marchetti C, Legnani C, Cavallari E, Castoldi E, Mascoli F, Ardissino D, Palareti G, Bernardi F: The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease. Arterioscler Thromb 1997, 17:2418-2422.
8. Von Depka Prondzinski M, Eisert R, Oberkannis C, Aschermann G, Barthels M, Ganser A: Thrombosis and prothrombin G → A mutation detected by rapid PCR and allele specific hybridisation [abstract]. Blood 1997, 90:14Ba.
9. Hessner MJ, Luhm RA, Endres JL, Han KS, Friedman KD, Montgomery RR: Allelic frequencies of prothrombin G20210A, factor V G1691A (Leiden) and 5,10 methylene tetrahydrofolate reductase C677T determined by triplex allele specific PCR in seven different populations [abstract]. Blood 1997, 90:116b.
10. Ripoll L, Paulin D, Thomas S, Drouet LO: Multiplex PCR-mediated site-directed mutagenesis for one-step determination of Factor V Leiden and G20210A transition in the prothrombin gene. Thromb Haemost 1997, 78:960-961.
11. Watzke HH, Schüttrumpf J, Graf S, Huber K, Panzer S: Increased prevalence of a polymorphism in the gene coding for human prothrombin in patients with coronary heart disease. Thromb Res 1997, 87:521-526.
12. Arruda VR, Annichino-Bizzacchi JM, GonÇalves MS, Costa FF: Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease. Thromb Haemost 1997, 78:1430-1433.
13. Alhenc-Gelas M, Le Cam Ducker V, Emmerich J, Frebourg T, Fiessinger JN, Borg JY, Aiach M: The A20210 allele of the prothrombin gene is not frequently associated with the Factor V Arg 506 to GIn mutation in thrombophilic families. Blood 1997, 90:1711
14. Martinelli J, Franchi F, Akwan S, Bettini P, Merati G, Mannucci PM: The transition G to A at position 20210 in the 3′-untranslated region of the prothrombin gene is not associated with cerebral ischemia. Blood 1997, 90:3806
15. De Stefano V, Chiusolo P, Paciaroni K, Di Mario A, Casorelli J, Rossi E, Leone G: Prevalence of the prothrombin gene mutation 20210 G to A in patients with venous thromboembolic disease [abstract]. Blood 1997, 90:148a.
16. Salomon O, Zivelin A, Dardik R, Inbal A, Varon D, Martinowitzll, Mani A, Lubetsky A, Steinberg DM, Seligsohn U: Risk assessment of single, double and triple prothrombotic polymorphisms in patients with idiopathic venous thromboembolism [abstract]. Blood 1997, 90:256a.
17. Zivelin A, Rosenberg N, Faier S, Seligsohn U: Factor II gene 20210A polymorphism associated with venous thrombosis probably has a common ancestry [abstract]. Blood 1997, 90:256a.
18. Corral J, Gonzalez-Conejero R, Lozano ML, Rivera J, Heras M, Vicente V: The venous thrombosis risk factor 20210A allele of the prothrombin gene is not a major risk factor for arterial thrombotic disease. Br J Haematol 1997, 99:304-307.
19. Hillarp A, Zöller B, Svensson PJ, Dahlbäck B: The 20210A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep vein thrombosis. Thromb Haemost 1997, 78:990-992.
20. Brown K, Luddington R, Williamson D, Baker P, Baglin T: Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′ untranslated region of the prothrombin gene. Br J Haematol 1997, 98:907-909.
21. Cumming AM, Keeney S, Salden A, Bhavnami M, Shwe KH, Hay CRM: The prothrombin gene G20210A variant: prevalence in a UK anticoagulant clinic population. Br J Haematol 1997, 98:353-355.
22. Makris M, Preston FE, Beauchamp NJ, Cooper PC, Daly ME, Hampton KK, Bayliss P, Peake IR, Miller GJ: Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb Haemost 1997, 78:1426-1429.
23. Howard TE, Marusa M, Boisza J, Young A, Sequeira J, Channell C, Guy C, Benson E, Duncan A: The prothrombin gene 3′-untranslated region mutation is frequently associated with factor V Leiden in thrombophilic patients and shows ethnic-specific variation in allele frequency. Blood 1998, 91:1092
24. Rosendaal FR, Siscovick DS, Schwartz SM, Psaty BM, Raghunathan TE, Vos HL: A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood 1997, 90:1747-1750.
25. Dilley A, Hooper WC, Austin H, Lally C, Wenger NK, Evatt BL: The prevalence of the prothrombin 20210 G → A variant in African-americans [abstract]. Blood 1997, 90:148a.
26. Howard TE, Marusa M, Channell C, Duncan A: A patient homozygous for a mutation in the prothrombin gene 3′-untranslated region associated with massive thrombosis. Blood Coagul Fibrinotysis 1997, 8:316-319.
27. Koeleman BPC, Reitsma PH, Allaart CF, Bertina RM: Activated protein C resistance as an additional factor for thrombosis in protein C deficient patients. Blood 1994, 84:1031-1035.
28. Zöller B, Berntsdotter A, Garcia de Frutos P, Dahlbäck B: Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 1995, 85:3518-3523.
29. Van Boven HH, Reitsma PH, Rosendaal FR, Bayston TA, Chowdhury V, Bauer KA, Scharrer I, Conard J, Lane Da: Factor V Leiden (FVR506Q) in families with inherited antithrombin deficiency. Thromb Haemost 1996, 75:417-421.
30. Lensen RPM, Rosendaal FR, Koster T, Allaart CF, de Ronde H, Vandenbroucke JP, Reitsma PH, Bertina RM: Apparent different thrombotic tendency in patients with factor V Leiden and protein C deficiency due to selection of patients. Blood 1996, 88:4205-4208.
31. Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM: High risk of cerebral-vein thrombosis in carriers of prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 1998, 338:1793-1797.
32. Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Rosendaal FR: Increased risk of venous thrombosis in oral contraceptive users who are carriers of factor V Leiden. Lancet 1994, 344:1453-1457.
33. Hoggen CJM, Manger Cats V, Bertina RM, Rosendaal FR: Interaction of coagulation defects and cardiovascular risk factors. Increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation 1998, 97:1037-1041.
34. Rosendaal FR, Siscovick DS, Schwartz SM, Beverty RK, Psaty BM, Longstreth WT Jr., Raghunathan TE, Koepsell TD, Reitsma PH: Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 1997, 89:2817-2821.